Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 90
Filtrar
1.
Ann Dermatol Venereol ; 135(5): 380-3, 2008 May.
Artículo en Francés | MEDLINE | ID: mdl-18457724

RESUMEN

BACKGROUND: Leishmaniasis covers three well-individualized clinical variants, each due to individual species found in different geographic areas. Herein we report the first case of cutaneous leishmaniasis due to Leishmania major involving bone marrow in an AIDS patient in Burkina Faso. CASE REPORT: A 38-year-old HIV-positive man presented with generalized, copper-coloured, painless, infiltrated, itching, papulonodular lesions present over the previous 10 months. Skin biopsy confirmed the diagnosis of diffuse cutaneous leishmaniasis. The bone-marrow smear showed numerous leishmania. The culture was positive and L. major was identified. The patient was being treated with antiretroviral medication and a pentavalent antimonial compound. The disease progression consisted of attacks and remissions separated by an average of three weeks. DISCUSSION: L. major is the Leishmania species identified in Burkina Faso. It is responsible for typical cutaneous leishmaniasis but particular clinical forms have been described in immunodeficient patients, especially with diffuse cutaneous involvement. The spread of L. major infection to bone marrow could represent a public health problem in our country, where the HIV epidemic is still not under control, and particular vigilance is thus called for.


Asunto(s)
Médula Ósea/parasitología , Infecciones por VIH/complicaciones , Leishmaniasis Cutánea/complicaciones , Adulto , Animales , Fármacos Anti-VIH/uso terapéutico , Antiprotozoarios/uso terapéutico , Burkina Faso , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/parasitología , Humanos , Leishmania major/efectos de los fármacos , Leishmania major/aislamiento & purificación , Leishmaniasis Cutánea/tratamiento farmacológico , Masculino , Resultado del Tratamiento
8.
Diagn Microbiol Infect Dis ; 37(3): 181-5, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10904191

RESUMEN

The present study was designed to evaluate the sensitivity and specificity of AMP CT (Gen-Probe Incorporated, San Diego, CA, USA) on urogenital specimens taken from symptomatic patients and on first void urine (FVU) specimens from asymptomatic patients. In symptomatic patients, 618 specimens from 140 men (140 urethral swabs and 140 FVU) and 202 women (202 endocervical swabs and 136 FVU) were tested by using cell culture, AMP CT and Amplicor Chlamydia trachomatis MWP (microwell plate) (Roche Diagnostics, Somerville, NJ, USA) on genital samples, and AMP CT and Amplicor on FVU. A clinical specimen was considered to be truly positive if either the cell culture was positive and/or both AMP CT and Amplicor were positive. In the asymptomatic population, a total of 300 FVU (136 women and 164 men) were tested by four amplification methods, AMP CT, LCx (Abbott, Abbott Park, IL, USA), Amplicor MWP, and Cobas Amplicor. A subject was considered to be infected when two or more amplification methods were positive. In the symptomatic population (prevalence 13%), concordant results were observed in 320/342 cases (93.5%). After analysis of discordant results, the sensitivity of AMP CT, Amplicor, and culture was 100%, 95.5%, 68.8%, respectively, and the specificity was 98.3%, 99.3%, 100% respectively. The number of false negative results by AMP CT in urine, probably due to labile inhibitors, was 3/276 (1%). In the asymptomatic population, the results were concordant in 298/300 (99.3%), seven positive and 291 negative. Two results were considered false positives, one by Cobas Amplicor, one by AMP CT. Compared to other amplification methods, AMP CT is at least as sensitive for the identification of chlamydial infection in symptomatic and asymptomatic men and women on genital or urine specimens.


Asunto(s)
Infecciones por Chlamydia/diagnóstico , Chlamydia trachomatis/crecimiento & desarrollo , Sistema Urogenital/microbiología , Adulto , Técnicas Bacteriológicas , Infecciones por Chlamydia/microbiología , Femenino , Humanos , Masculino , Reacción en Cadena de la Polimerasa , ARN Ribosómico/análisis , Juego de Reactivos para Diagnóstico , Sensibilidad y Especificidad
9.
Ann Dermatol Venereol ; 127(1): 73-6, 2000 Jan.
Artículo en Francés | MEDLINE | ID: mdl-10717569

RESUMEN

BACKGROUND: POEMS syndrome is a rare form of plasma-cell dyscrasia characterized by the various association of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal component and Skin changes. The most frequent skin changes such as hyperpigmentation, hypertrichosis, scleroderma-like skin thickening and angiomas are not pathognomonic but nearly constant. However, they are rarely isolated. CASE REPORT: A 57-year-old Caucasian woman presented with a 6 month history of skin thickening on both hands and feet, Raynaud's phenomenon and facial telangiectasias. Physical examination on presentation revealed hepatomegaly, signs of a sensorimotor peripheral neuropathy which was demyelinating in type on electrophysiological assessment, and ankle edemas. Initial laboratory investigations revealed a platelet count of 900 000/mm(3), a monoclonal IgG lambda gammapathy. Plasma-cells were slightly increased (10 p. 100 of marrow elements) and full skeletal radiographs showed no focal osteosclerotic or lytic lesion. A diagnosis of POEMS syndrome was made. The patient was treated with tamoxifen, methylprednisolone and plasmapheresis without improvement in polyneuropathy or in skin changes. DISCUSSION: Our patient satisfied the criteria for POEMS syndrome. The most typical feature here was the scleroderma-like skin change, which has been recognized by other authors. But, in the present case, Raynaud's phenomenon, skin thickening and facial telangiectasias were present 6 months before the diagnosis, and initially suggestive of systemic scleroderma, confirmed histologically. The pathogenesis of POEMS syndrome might be regarded as the result of a marked activation of the proinflammatory cytokine network, but an increase in serum Vascular Endothelial Growth Factor (VEGF) levels could well account for other manifestations such as skin thickening.


Asunto(s)
Síndrome POEMS/diagnóstico , Esclerodermia Sistémica/diagnóstico , Piel/patología , Antiinflamatorios/uso terapéutico , Biopsia , Diagnóstico Diferencial , Femenino , Humanos , Metilprednisolona/uso terapéutico , Persona de Mediana Edad , Síndrome POEMS/patología , Síndrome POEMS/terapia , Plasmaféresis , Moduladores Selectivos de los Receptores de Estrógeno/uso terapéutico , Tamoxifeno/uso terapéutico
11.
Rev Epidemiol Sante Publique ; 47(2): 109-17, 1999 Apr.
Artículo en Francés | MEDLINE | ID: mdl-10367298

RESUMEN

BACKGROUND: To study behavioral risk factors of Kaposi's sarcoma (KS) among HIV infected homosexuals in Bordeaux, southwest France. METHODS: A case-control study was performed within the Aquitaine Cohort. Cases of KS surviving in 1995 and homosexuals were systematically enrolled. For each case, two controls were selected among homosexuals surviving in the cohort. Cases and controls were matched on year of diagnosis of HIV infection. Data collection was based on a self administered questionnaire focusing on use of recreational drugs, detailed sexual practices and sexually transmitted diseases in the year preceeding the diagnosis of HIV infection, in the year after the HIV diagnosis and in the year preceeding the diagnosis of KS (or an equivalent period of time for controls). RESULTS: Twelve cases were matched to 2 controls, 15 cases to one control and 13 cases remained unmatched. Matched analysis identified an association between KS and regular sexual partner (odds ratio = 0.07; 95% confidence interval: 0.01-0.52 and p < 0.001) and active and passive oro-anal intercourse before HIV diagnosis and before KS diagnosis (p = 0.01). In the unmatched analysis including all cases, we found an association between KS and the overall number of sexual partners (p < 0.03) for all periods of interest. CONCLUSIONS: This case-control study identified sexual practices in favor of a sexually transmitted agent of KS.


Asunto(s)
Infecciones por VIH/complicaciones , Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Homosexualidad , Sarcoma de Kaposi/mortalidad , Sarcoma de Kaposi/virología , Estudios de Casos y Controles , Francia/epidemiología , Infecciones por VIH/transmisión , Homosexualidad/psicología , Homosexualidad/estadística & datos numéricos , Humanos , Masculino , Factores de Riesgo , Sarcoma de Kaposi/psicología , Parejas Sexuales , Encuestas y Cuestionarios , Análisis de Supervivencia
12.
Ann Dermatol Venereol ; 125(3): 196-8, 1998 Mar.
Artículo en Francés | MEDLINE | ID: mdl-9747249

RESUMEN

BACKGROUND: Rouget du porc, or swine erysipelas, usually occurs in man as Rosenbach's erysipeloid. Septicemic forms are more uncommon and can be associated with dermal involvement far from the site of inoculation. We report a case in a patient given corticosteroid therapy for systematic lupus. CASE REPORT: A 50-year-old farmer was seen with fever, infiltrative erythema of the long finger and dorsal lesions on the ring finger which developed after a skin lesions caused by a duck. The diagnosis of septicemic rouget du porc was made after isolating the germ from blood cultures. There was no associated endocarditis. Fever and skin lesions totally regressed after treatment with ceftriaxone. DISCUSSION: The diagnosis of erysipeloid was supported by epidemiologic arguments and characteristic clinical features. The corticosteroid therapy was probably a favoring factor for development of septicemia. Positive diagnosis is usually obtained from blood culture but the germ can be isolated from skin biopsies at the site of inoculation. Our patient was free of endocarditis which should always be suspected. Endocarditis is frequent and often fatal. Intravenous high-dose penicillin G is recommanded treatment.


Asunto(s)
Bacteriemia/diagnóstico , Mordeduras y Picaduras/complicaciones , Patos , Erisipeloide/diagnóstico , Enfermedades Cutáneas Infecciosas/diagnóstico , Animales , Bacteriemia/tratamiento farmacológico , Bacteriemia/etiología , Ceftriaxona/uso terapéutico , Cefalosporinas/uso terapéutico , Erisipeloide/tratamiento farmacológico , Erisipeloide/etiología , Humanos , Masculino , Persona de Mediana Edad , Enfermedades Cutáneas Infecciosas/tratamiento farmacológico , Enfermedades Cutáneas Infecciosas/etiología
13.
Ann Dermatol Venereol ; 125(5): 335-8, 1998 May.
Artículo en Francés | MEDLINE | ID: mdl-9747283

RESUMEN

BACKGROUND: Erdheim Chester disease (MEC) is a rare non-Langerhans cell histiocytosis characterized by multi-visceral involvement. We report a case of MEC associated with Langerhans cell histiocytosis (HCL). CASE REPORT: A 46-year-old women presented skin and vulvar localization of HCL associated with typical MEC bone involvement. Despite chemotherapy (vinblastine) and prednisone, the disease progressed to involve the central nervous system, leading to fatal outcome. Post-mortem examination showed HCL in skin, MEC in bones and central nervous system, and intermediate histiocytic proliferation in the encephalon. DISCUSSION: Usually, MEC and HCL are considered as distinct entities. MEC is characterized by a xanthogranulomatous proliferation of CD 68+ foamy histiocytes nested in fibrosis, and HCL by a proliferation of PS 100+ and CD1a+ Langerhans cells. However, our observation, as well as previous reports, suggests that MEC is part of the HCL spectrum.


Asunto(s)
Histiocitosis de Células de Langerhans/diagnóstico , Histiocitosis de Células no Langerhans/diagnóstico , Enfermedades Óseas/diagnóstico , Enfermedades Óseas/patología , Encefalopatías/diagnóstico , Encefalopatías/patología , Diagnóstico Diferencial , Resultado Fatal , Femenino , Histiocitos/patología , Histiocitosis de Células de Langerhans/patología , Histiocitosis de Células no Langerhans/patología , Humanos , Persona de Mediana Edad , Piel/patología , Enfermedades de la Piel/diagnóstico , Enfermedades de la Piel/patología , Enfermedades de la Vulva/diagnóstico , Enfermedades de la Vulva/patología
14.
Ann Dermatol Venereol ; 125(8): 505-8, 1998 Aug.
Artículo en Francés | MEDLINE | ID: mdl-9747316

RESUMEN

BACKGROUND: We report a case of sensitization to estrogen. CASE REPORT: A 40-year-old woman consulted for skin disorders which followed a cyclic pattern. At each menses, the patient developed pruritus and erythematous papulovesicular lesions over the members and trunk. Estraderm patch contact dermatitis was evident. Prick and patch tests with alcoholic solutions of estrone alone were positive. Serum tests were positive for anti-ethinyl-estradiol antibodies and anti-progesterone antibodies. DISCUSSION: Autoimmune dermatitis can be caused by sensitization to endogenous or exogenous sex hormones. Clinical manifestations and histological findings are variable and non-specific. The cyclic nature of the manifestations is however quite suggestive. Positive prick and patch tests performed with alcohol solutions of the hormones may give the diagnosis and serum tests may be positive for specific anti-steroid antibodies. These complementary explorations are however difficult to perform and interpret and definitive diagnosis is based on an association of clinical findings, skin tests, laboratory tests and the clinical course. In case of progesterone sensitization, the treatment of choice is estrogen inhibition of ovulation. For estrogen sensitization, anti-estrogen treatment appears to be more effective. Finally, bilateral ovariectomy may be required in difficult cases.


Asunto(s)
Erupciones por Medicamentos/etiología , Terapia de Reemplazo de Estrógeno/efectos adversos , Estrona/efectos adversos , Etinilestradiol/efectos adversos , Progesterona/efectos adversos , Administración Cutánea , Adulto , Enfermedades Autoinmunes/inducido químicamente , Enfermedades Autoinmunes/diagnóstico , Estrona/administración & dosificación , Etinilestradiol/administración & dosificación , Femenino , Humanos , Pruebas Intradérmicas , Pruebas del Parche , Progesterona/administración & dosificación
15.
Ann Dermatol Venereol ; 125(12): 888-90, 1998 Dec.
Artículo en Francés | MEDLINE | ID: mdl-9922861

RESUMEN

BACKGROUND: We report a case of leprosy observed in a French woman who had lived in Africa 30 years earlier. The clinical presentation was misleading, suggesting connective tissue disease. CASE REPORT: A 69-year-old woman was hospitalized in April 1996 for inflammatory joint disease. The first manifestations had developed three years earlier and the patient had been on systemic corticosteroid therapy associated with anti-malarials since 1993. The clinical presentation progressively included neurological and skin manifestations. Histology examination gave the diagnosis of lepromatous leprosy. Three-drug anti-leprosy treatment in one oral dose was initiated. DISCUSSION: Chronic Mycobacterium leprae infection usually leads to overt leprosy with neurological and cutaneous involvement. Rheumatological forms are less common and found almost exclusively during leprous reactions. The association of inflammatory join pain with neurological and skin manifestations wrongly suggested vasculitis. In addition, the general corticosteroid therapy certainly was implicated in disease activation and progression to a purely lepromatous form.


Asunto(s)
Artritis/diagnóstico , Lepra Lepromatosa/diagnóstico , Anciano , Antimaláricos/uso terapéutico , Artritis/tratamiento farmacológico , Enfermedades del Tejido Conjuntivo/diagnóstico , Diagnóstico Diferencial , Femenino , Glucocorticoides/uso terapéutico , Humanos , Hidroxicloroquina/uso terapéutico , Leprostáticos/administración & dosificación , Leprostáticos/uso terapéutico , Lepra Lepromatosa/tratamiento farmacológico , Prednisolona/uso terapéutico
17.
Ann Dermatol Venereol ; 124(3): 248-50, 1997.
Artículo en Francés | MEDLINE | ID: mdl-9686058

RESUMEN

INTRODUCTION: Idiopathic hypereosinophilic syndrome is an uncommon disease often associated with diverse non-specific skin manifestations. Mucosal ulcerations suggest a myeloproliferative from with poor prognosis due to possible progression to malignant hemopathy or visceral complications. CASE REPORT: A 28-year-old man presented idiopathic hypereosinophilia with isolated mucosal ulcerations involving the buccal and genital areas. Laboratory results (hematology, CD25) suggested a myeloproliferative form. Treatment with alpha interferon (18 months) led to regression of the mucosal lesions and a decrease in the markers of eosinophil toxicity. There was no visceral involvement. DISCUSSION: Immunosuppression with/without high-dose alpha interferon is usually used for the treatment of hypereosinophilic syndrome. In our case favorable outcome was obtained with lower doses of alpha interferon than those reported in the literature. There was objective decrease in eosinophil toxicity (regular counts of hypodense eosinophils, CD25 or interleukin 2 soluble receptor) and no progression (malignant hemopathy, mortal visceral involvement).


Asunto(s)
Síndrome Hipereosinofílico/complicaciones , Mucosa Bucal , Úlceras Bucales/etiología , Adulto , Eosinófilos , Humanos , Síndrome Hipereosinofílico/tratamiento farmacológico , Interferón-alfa/uso terapéutico , Recuento de Leucocitos , Masculino , Úlceras Bucales/tratamiento farmacológico , Úlceras Bucales/patología , Resultado del Tratamiento
18.
Ann Dermatol Venereol ; 124(2): 176-81, 1997.
Artículo en Francés | MEDLINE | ID: mdl-9740832

RESUMEN

INTRODUCTION: Soft tissue melanoma was described in 1965 by Enzinger who used the term clear-cell sarcoma. In 1983, Chung and Enzinger coined the term soft tissue melanoma due to the immunohistochemical similarity with melanoma. We report a case of this rare type of melanoma. CASE REPORT: A 59-year-old woman had pain between the first two toes for 3 years. A subcutaneous tumor was found at examination. Histologically, the tumor was composed of weakly eosinophilic cell proliferation. Protein S100 and HMB45 were positive. The cells were organized in theques. Pathology diagnosis was soft tissue melanoma. Complete remission was obtained for 3 years when several local recurrences required surgery and chemotherapy then surgery and radiotherapy. Complete remission has been achieved for 9 months. DISCUSSION: This case presented the main characteristics of soft tissue melanoma as described in a review of 209 analyzable cases reported in the literature. This tumor occurs in young subjects with no sex or race predominance. It is an ubiquitous tumor which develops in close relation with tendons and aponevroses, usually in limbs (especially feet). Pain is sometimes the revealing manifestation, but the tumor is often asymptomatic, so the volume is often important at diagnosis. Pathology examination shows rather monomorphic proliferation of cells with a clear or weakly eosinophilic cytoplasm grouped in clusters or theques separated by fibrous septa. Intracytoplasmic melanin is sometimes observed, indicating interest of protein S100 and HMB45 immunohistochemistry which is almost always positive. The principle differential diagnoses are metastasic melanoma and epithelioid sarcoma. Prognosis of soft tissue melanoma is similar to that in sarcomas with a high rate of local recurrence and metastases (lymph nodes, lungs). Mortality reaches 56 p. 100. Treatment is wide surgical exeresis. CONCLUSION: Soft tissue melanoma is a rare tumor of the melanocyte. It differs from melanoma by the population involved, its clinical expression and its prognosis which is similar to that in sarcoma.


Asunto(s)
Melanoma/diagnóstico , Neoplasias de los Tejidos Blandos/diagnóstico , Terapia Combinada , Femenino , Humanos , Melanoma/terapia , Persona de Mediana Edad , Metástasis de la Neoplasia , Recurrencia Local de Neoplasia , Neoplasias de los Tejidos Blandos/terapia
19.
Rev Prat ; 46(16): 1952-60, 1996 Oct 15.
Artículo en Francés | MEDLINE | ID: mdl-9005519

RESUMEN

Herpes is the first cause of genital ulcers, recurrences are unpredictable and asymptomatic viral excretion is frequent. Herpes simplex virus 2 is responsible for genital infection in 80% of cases, but the incidence of Herpes simplex virus 1 is rising. New diagnostics methods are developing, batcellular viral culture remains gold standard. Oral aciclovir is the standard treatment, and directions for use are strictly codified. In pregnant women a new preventing project is proposed, it does not prevent transmission during asymptomatic viral excretion. In immunocompromise patients Herpes is frequent severe and sometimes aciclovir resistant.


Asunto(s)
Herpes Genital/transmisión , Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Femenino , Herpes Genital/tratamiento farmacológico , Humanos , Masculino , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...